Prof Annette Byrne, RCSI, COLOSSUS Coordinator, NPIC Director In Ireland, a new National Preclinical Imaging Centre (NPIC) which will provide enhanced research data to inform new clinical trials that aim to improve patient outcomes, has been awarded funding of €3.4 million under Science Foundation Ireland's (SFI) Research Infrastructure Programme. COLOSSUS Coordinator, Prof Annette [...]
This month we feature our partners at HalioDx. HalioDx (https://www.haliodx.com/) is the pioneer of immuno-oncology diagnostic, a transforming approach of cancer care that benefits from novel and deep understanding of the tumour immune microenvironment. The company provides a unique and extensive range of proprietary assays that allow it to extract from the immune contexture of [...]
An independent review entitled “Immunoscore®: A Diagnostic Assay for Clinical Management of Colon Cancer” is published on March 30th, 2020 in Molecular Diagnosis and Therapy (Blair, H.A. Mol Diagn Ther (2020) a specialized journal of Springer Nature group that provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use [...]
Cancer Trials Ireland was established in 1996 under the name of Irish Cooperative Oncology Research Group (ICORG). A group of cancer consultants had the aim to create more opportunities for patients to access cutting edge treatments by putting a formal structure in place, which could make Ireland more attractive as a location to international cancer [...]
Hear ye! Hear ye! The Spring 2020 COLOSSUS newsletter is out now! Read the latest update on the COLOSSUS translational study from partners at Cancer Trials Ireland, a spotlight feature on our partner HalioDx, the dissemination round-up and much more!
VHIO hosts interactive public meeting drawing together stakeholders in colorectal cancer treatment and care
Principal Investigators (PIs) involved in the COLOSSUS and MoTriColor projects hosted a packed public meeting for people with colorectal cancer, their carers, and relatives on February 27, 2020, at the Vall d´Hebron Institute of Oncology in Barcelona. Berta Colldeforns Riera of VHIO, one of the co-organizers of this interactive event reported: "Everyone seemed very interested [...]
VIB hosts Tumor Heterogeneity, Plasticity and Therapy meeting, 14-15 May 2020- travel grants are available
Our partners VIB, a non-profit life sciences research institute in Belgium, is pleased to announce the first Tumor Heterogeneity, Plasticity and Therapy meeting which will be held on May 14-15, 2020 in the historical city of Leuven, Belgium. The upcoming deadlines are: Travel Grant application deadline: 27 February 2020 Abstract deadline: 12 March 2020 When you submit your abstract for [...]
Digestive Cancers Europe, (DiCE) formerly EuropaColon, has published a new resource, "A Guide to caring for someone with Colorectal Cancer". Read it here. Digestive Cancers Europe is the umbrella organisation in Europe, representing the voice of patients with digestive cancers (oesophageal, gastric, colon, rectum, pancreatic and rare cancers), their families and their carers. It is [...]
COLOSSUS teams up with MoTriColor for February 27th event “Advances and new horizons in the diagnosis and treatment of colorectal cancer”
In advance of the launch of Colorectal Cancer Awareness Month (March) 2020, COLOSSUS partners at VHIO have organized a special public event on Thursday, the 27th of February, from 18:00h-20:00h, at C/Rosselló, 231, 2-1 in Barcelona. Download the promotional flyer in PDF here: What is changing in the diagnosis and treatment of CRC_ (003) As [...]
Congratulations to authors Wolf H.Fridman, Ian Miller, CatherineSautès-Fridman, and Annette T.Byrne for their most recent paper published in Volume 158, Issue 2 edition of Gastroenterology dated January 2020, (pages 303-321). The open-access review is entitled: Therapeutic Targeting of the Colorectal Tumor Stroma.